World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
101
Citations
43106
World Ranking
692
National Ranking
20

Medicine

D-Index
101
Citations
43155
World Ranking
7894
National Ranking
198

Yutaka Kawakami publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yutaka Kawakami sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 486 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yutaka Kawakami D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yutaka Kawakami sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 101 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yutaka Kawakami is affiliated with Keio University in Japan and has a substantial body of research primarily in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work encompasses multiple subfields, notably Oncology, Immunology, Molecular Biology, Cancer Research, and Genetics.

The research topics frequently addressed by Kawakami include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T Cell Therapy Research, Cancer, Lipids, and Metabolism, Immune Cell Function and Interaction, Gastric Cancer Management and Outcomes, and Colorectal Cancer Treatments and Studies.

Kawakami has published extensively in several key journals. The most frequent publication venues include Cancer Science with seven publications, Annals of Oncology with four, Journal of Clinical Oncology with three, and both International Journal of Molecular Sciences and BMC Cancer with two publications each.

Recent notable papers authored by or involving Kawakami cover various topics related to cancer treatment and immune regulation. These include:

  • "Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer," 2020, Clinical Cancer Research
  • "Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody," 2022, Journal for ImmunoTherapy of Cancer
  • "Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3," 2020, Cancer Science
  • "AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma," 2021, The Journal of Experimental Medicine
  • "Immune-resistant mechanisms in cancer immunotherapy," 2020, International Journal of Clinical Oncology

Kawakami collaborates frequently with other researchers, including Tomonori Yaguchi, Shigeki Ohta, Takashi Iwata, Ryota Tamura, and Yukina Morimoto.

Best Publications

  • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

    Steven A. Rosenberg;James C. Yang;Douglas J. Schwartzentruber;Patrick Hwu

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

    Yutaka Kawakami;Siona Eliyahu;Cynthia H. Delgado;Paul F. Robbins

  • Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

    Y Kawakami;S Eliyahu;C H Delgado;P F Robbins

  • Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

    Yutaka Kawakami;Siona Eliyahu;Kazuyasu Sakaguchi;Paul F. Robbins

  • A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

    Takeshi Tanoue;Satoru Morita;Damian R. Plichta;Ashwin N. Skelly

  • Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

    Chie Kudo-Saito;Hiromi Shirako;Tadashi Takeuchi;Yutaka Kawakami

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Identification of human cancers deficient in antigen processing.

    Nicholas P. Restifo;Fernando Esquivel;Yutaka Kawakami;Jonathan W. Yewdell

  • The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

    Hidetoshi Sumimoto;Fumie Imabayashi;Tomoko Iwata;Yutaka Kawakami

  • Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

    A.B.H. Bakker;M.W.J. Schreurs;A.J. de Boer;Y. Kawakami

  • Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.

    Maria R. Parkhurst;Michael L. Salgaller;Scott Southwood;Paul F. Robbins

  • RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

    Shinji Sato;Kana Hoshino;Takashi Satoh;Tomonobu Fujita

  • Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.

    Y. Kawakami;S. Eliyahu;C. Jennings;K. Sakaguchi

  • A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.

    Paul F. Robbins;Mona El-Gamil;Yong F. Li;Yutaka Kawakami

  • Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

    Nicholas P. Restifo;Francesco M. Marincola;Yutaka Kawakami;Jeff Taubenberger

  • Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation

    Masataka Kuwana;Yuka Okazaki;Hiroaki Kodama;Keisuke Izumi

  • Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.

    Licia Rivoltini;Yutaka Kawakami;Kazuyasu Sakaguchi;Scott Southwood

  • Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

    Rong Fu Wang;Steven A. Rosenberg

Frequent Co-Authors

Masataka Kuwana
Masataka Kuwana Nippon Medical School
Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Kazuo Tsubota
Kazuo Tsubota Keio University
Yasuo Ikeda
Yasuo Ikeda Waseda University
Hideyuki Okano
Hideyuki Okano Keio University
Paul F. Robbins
Paul F. Robbins National Cancer Institute
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Francesco M. Marincola
Francesco M. Marincola National Institutes of Health
Yumi Matsuzaki
Yumi Matsuzaki Shimane University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can open diverse career opportunities. Programs like the best pmhnp programs online offer specialized training in psychiatric mental health nursing, which can complement immunology expertise, especially in neuroimmunology or psychoneuroimmunology fields.

Cost is often an important consideration, and it's useful to look at affordable pmhnp programs that maintain quality education while being budget-friendly. These alternatives make advanced practice degrees accessible without compromising clinical experience.

Career advancement and salary potential vary by specialization. For those pursuing a Doctor of Nursing Practice (DNP) degree, understanding the dnp salary by specialty can guide informed decisions about which focus areas align with financial and professional goals.

Additionally, transitioning from roles like Family Nurse Practitioner (FNP) to specialized acute care positions is common. Resources on acnp programs provide valuable guidance for making this shift, highlighting learning pathways and certification requirements to enhance career versatility.

Best Scientists Citing Yutaka Kawakami

Trending Scientists

Recently Published Articles